{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:08:44Z","timestamp":1794568124086,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US NIH\/NIDA","award":["DA037820"],"award-info":[{"award-number":["DA037820"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugpo.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:16:03Z","timestamp":1500596163000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":405,"special_numbering":"C","title":["Fentanyl in the US heroin supply: A rapidly changing risk environment"],"prefix":"10.1016","volume":"46","author":[{"given":"Daniel","family":"Ciccarone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.06.010_bib0005","series-title":"Letter to Congress: Response to questions concerning fentanyl","author":"Baum","year":"2017"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: Prohibition\u2019s Iron law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.010_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/dta.1954","article-title":"Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project","volume":"9","author":"Brunt","year":"2017","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0020","series-title":"CCENDU bulletin","article-title":"Deaths involving fentanyl in Canada 2009\u20132014","author":"Canadian Community Epidemiology Network on Drug Use, CCENDU","year":"2015"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugpo.2016.04.017","article-title":"Results of an international drug testing service for cryptomarket users","volume":"35","author":"Caudevilla","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0035","series-title":"Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health","author":"Center for Behavioral Health Statistics and Quality, CBHSQ","year":"2015"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0040","series-title":"Drug overdose death data","author":"Centers for Disease Control and Prevention, CDC","year":"2016"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.010_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.drugpo.2005.06.001","article-title":"The political economy of heroin: Regional markets, practices and consequences","volume":"16","author":"Ciccarone","year":"2005","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.010_bib0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: Exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u2018heroin\u2019","volume":"46","author":"Ciccarone","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.010_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.drugpo.2008.12.001","article-title":"Impact of South American heroin on the US heroin market 1993\u20132004","volume":"20","author":"Ciccarone","year":"2009","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.04.009","article-title":"Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions","volume":"163","author":"Ciccarone","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.010_bib0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0075","series-title":"Dark Paradise: A History of Opiate Addiction in America Cambridge","author":"Courtwright","year":"2001"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0080","series-title":"DEA Intelligence Report","article-title":"National heroin threat assessment summary\u2014Updated","author":"US Drug Enforcement Administration, DEA","year":"2016"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0085","series-title":"National forensic laboratory information system: Year 2015 annual report. Washington, DC: Drug Enforcement Administration","author":"Drug Enforcement Administration Diversion Control Division, DEA","year":"2016"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0090","series-title":"DEA intelligence report. Washington, DC: Department of Justice.","article-title":"The heroin signature program and heroin domestic monitor reports 2014","author":"Drug Enforcement Administration, DEA","year":"2016"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.010_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugpo.2008.02.016","article-title":"Fentanyl use among street drug users in Toronto, Canada: Behavioural dynamics and public health implications","volume":"20","author":"Firestone","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"7","key":"10.1016\/j.drugpo.2017.06.010_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1615145","article-title":"Addressing the fentanyl threat to public health","volume":"376","author":"Frank","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugpo.2017.05.052","article-title":"Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains","volume":"46","author":"Gilbert","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"33","key":"10.1016\/j.drugpo.2017.06.010_bib0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid\u2013involved overdose deaths\u201427 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.010_bib0120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.010_bib0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2007.09.002","article-title":"Behavioral economic analysis of drug preference using multiple choice procedure data","volume":"93","author":"Greenwald","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0130","series-title":"The Global State of Harm Reduction 2016","author":"Harm Reduction International, UK","year":"2017"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.010_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2014.09.009","article-title":"\u201cIt\u2019s Russian roulette\u201d: Adulteration, adverse effects and drug use transitions during the 2010\/2011 United Kingdom heroin shortage","volume":"26","author":"Harris","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0145","article-title":"Drug deaths in America are rising faster than ever","author":"Katz","year":"2017","journal-title":"New York Times"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0150","article-title":"You draw it: Just how bad is the drug overdose epidemic?","author":"Katz","year":"2017","journal-title":"New York Times"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","article-title":"A systematic review of injecting-related injury and disease among people who inject drugs","volume":"171","author":"Larney","year":"2017","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2016.08.004","article-title":"Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre","volume":"37","author":"Latimer","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugpo.2017.05.057","article-title":"Toxicosurveillance in the US Opioid Epidemic","volume":"46","author":"Lucyk","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.010_bib0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamapsychiatry.2017.0163","article-title":"The surge of opioid use, addiction, and overdoses: Responsibility and response of the US health care system","volume":"74","author":"Madras","year":"2017","journal-title":"Jama Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.010_bib0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"\u201cEvery \u2018never\u2019 I ever said came true\u201d: Transition from opioid to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugpo.2017.05.029","article-title":"Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA","volume":"46","author":"Marshall","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"9775","key":"10.1016\/j.drugpo.2017.06.010_bib0190","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: A retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0195","series-title":"The Politics of Heroin: CIA Complicity in the Global Drug Trade, Afghanistan, Southeast Asia, Central America, Columbia","author":"McCoy","year":"2003"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0200","series-title":"Deaths of despair and support for Trump in the 2016 Presidential Election","author":"Monnat","year":"2016"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0205","series-title":"The World Heroin Market: Can Supply be Cut?","author":"Paoli","year":"2009"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0215","series-title":"Dreamland: The True Tale of America\u2019s Opiate Epidemic","author":"Quinones","year":"2015"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.010_bib0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","volume":"32","author":"Roxburgh","year":"2013","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0225","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance","volume":"46","author":"Slavova","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: Fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations","volume":"46","author":"Unick","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.010_bib0245","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0250","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/603a2a94-en","author":"United Nations Office of Drug Control, UNODC","year":"2016"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.010_bib0255","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014","volume":"65","author":"Warner","year":"2016","journal-title":"National vital statistics reports: From Centers for Disease Control and Prevention. Hyattsville, MD: National Center for Health Statistics, National Vital Statistics System"},{"key":"10.1016\/j.drugpo.2017.06.010_bib0260","series-title":"NCHS data brief","article-title":"Mortality in the United States, 2015","author":"Xu","year":"2016"},{"issue":"17","key":"10.1016\/j.drugpo.2017.06.010_bib0265","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T07:39:09Z","timestamp":1659253149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":53,"alternative-id":["S0955395917301810"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.010","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl in the US heroin supply: A rapidly changing risk environment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}